Abstract
The utility of morphine for the treatment of chronic pain is limited by the development of analgesic tolerance. Adenylyl cyclase (AC) superactivation, induced by chronic opioid agonist administration, is regarded as one of the molecular mechanisms leading to tolerance. In the present work, we tested the role of Raf-1 in morphine-mediated AC superactivation in CHO cells stably expressing the human μ-opioid receptor. We found that pretreatment of CHO cells stably expressing the human μ-opioid receptor with the selective Raf-1 inhibitor, 3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodo-1,3-dihydroindol-2-one (GW5074, 10 μM, 60 min) completely abolished chronic morphine-mediated AC superactivation (P < 0.01). This finding indicates that Raf-1 may have a crucial role in compensatory feedback regulation of cellular cAMP levels by clinically important opioid analgesics.
Original language | English (US) |
---|---|
Pages (from-to) | 57-59 |
Number of pages | 3 |
Journal | European Journal of Pharmacology |
Volume | 540 |
Issue number | 1-3 |
DOIs | |
State | Published - Jul 1 2006 |
Keywords
- Adenylyl cyclase superactivation
- Human μ-opioid receptor
- Raf-1
ASJC Scopus subject areas
- Pharmacology